You just read:

Viela Bio Spins Out of MedImmune; Launches with Up to $250 Million Series A Financing from Investor Consortium Led by Boyu Capital, 6 Dimensions Capital, and Hillhouse Capital

News provided by

Viela Bio

Feb 28, 2018, 02:11 ET